Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Challenges in recognition and reporting of infections in immune deficiency
Bergmans, B., 2026, Ipskamp Printing. 396 p.Research output: Thesis › Doctoral Thesis
Open AccessFile19 Downloads (Pure) -
Exploring the pathogens in primary predominantly antibody deficiencies of unknown genetic origin
Bergmans, B., Fontane Pennock-Janssen, L., van Puijenbroek, E., van Hout, R., Murk, J.-L., de Vries, E. & The unPAD consortium, Dec 2025, In: Journal of Clinical Immunology. 46, 1, 12 p., 6.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile2 Downloads (Pure) -
Progressive multifocal leukoencephalopathy in rheumatoid arthritis and biological therapies: a case report and review of the literature
Bergmans, B., Roks, G., van Puijenbroek, E., de Vries, E. & Murk, J.-L., 24 Feb 2025, In: Journal of Medical Case Reports. 19, 1, 9 p., 72.Research output: Contribution to journal › Review article › peer-review
Open AccessFile5 Downloads (Pure) -
Burden of non-serious infections during biological use for rheumatoid arthritis
Bergmans, B., Jessurun, N., van Lint, J. H., Murk, J.-L., van Puijenbroek, E. & de Vries, E., 2024, In: PLOS ONE. 19, 2, 16 p., e0296821.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile2 Link opens in a new tab Citations (Scopus)23 Downloads (Pure) -
Infections in biological and targeted synthetic drug use in rheumatoid arthritis: Where do we stand? A scoping review and meta-analysis
Bergmans, B. J. M., Gebeyehu, B. Y., van Puijenbroek, E. P., Van Deun, K., Kleinberg, B., Murk, J. & de Vries, E., 2023, In: Rheumatology and Therapy. 10, 5, p. 1147-1165 19 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile4 Link opens in a new tab Citations (Scopus)110 Downloads (Pure)
-
High burden of non-serious infections during biological use for rheumatoid arthritis
Bergmans, B. J. M. (Speaker), Jessurun, N. (Speaker), van Lint, J. H. (Speaker), Murk, J.-L. (Speaker), van Puijenbroek, E. (Speaker) & de Vries, E. (Speaker)
27 Apr 2024 → 30 Apr 2024Activity: Talk or presentation types › Oral presentation › Professional
-
Infections in rheumatoid arthritis and biological use: A systematic review and meta-analysis
Bergmans, B. (Speaker), Gebeyehu, B. (Speaker), Murk, J.-L. (Speaker), van Puijenbroek, E. (Speaker) & de Vries, E. (Speaker)
12 Nov 2022 → 15 Nov 2022Activity: Talk or presentation types › Oral presentation › Professional
-
Infections in biological and targeted synthetic drug use in rheumatoid arthritis: Where do we stand? A scoping review and meta-analysis.
Bergmans, B. J. M. (Speaker), de Vries, E. (Speaker), Gebeyehu, B. Y. (Speaker), Kleinberg, B. (Speaker) & Van Deun, K. (Speaker)
12 Oct 2022 → 16 Oct 2022Activity: Talk or presentation types › Oral presentation › Professional
-
Infections in biological and targeted synthetic drug use in rheumatoid arthritis: Where do we stand? A scoping review and meta-analysis.
Bergmans, B. J. M. (Speaker), de Vries, E. (Speaker), Gebeyehu, B. Y. (Speaker), Kleinberg, B. (Speaker) & Van Deun, K. (Speaker)
12 Oct 2022 → 16 Oct 2022Activity: Talk or presentation types › Oral presentation › Professional
-
Routine healthcare data predicts which patients are at increased risk for severe infection while using immunomodulating drugs - A pilot study
Rijnen, M. M. C. (Speaker), Leopold, J. H. (Speaker), Bergmans, B. (Speaker), Murk, J.-L. (Speaker) & de Vries, E. (Speaker)
27 Sept 2021 → 29 Sept 2021Activity: Talk or presentation types › Oral presentation › Professional